Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

Ítems similars

• Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent
  per: Kanakry, Christopher G, et al.
  Publicat: (2015)
• Donor CD4(+) Foxp3(+) regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
  per: Ganguly, Sudipto, et al.
  Publicat: (2014)
• Absence of posttransplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using posttransplantation cyclophosphamide as graft-versus-host disease prophylaxis
  per: Kanakry, Jennifer A., et al.
  Publicat: (2013)
• Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
  per: Kasamon, Yvette L., et al.
  Publicat: (2017)
• Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide
  per: Kanakry, Christopher G., et al.
  Publicat: (2017)